MENU
KALV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

KalVista Pharmaceuticals (KALV) Earnings Date & Reports

A.I. Advisor
published Earnings

KALV is expected to report earnings to fall 37.14% to -57 cents per share on March 12

KalVista Pharmaceuticals KALV Stock Earnings Reports
Q1'25
Est.
$-0.57
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.31
Q1'24
Missed
by $0.09
The last earnings report on December 05 showed earnings per share of -91 cents, beating the estimate of -93 cents. With 152.15K shares outstanding, the current market capitalization sits at 427.47M.
View a ticker or compare two or three
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
55 Cambridge Parkway
Phone
+1 857 999-0075
Employees
118
Web
https://www.kalvista.com